


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-23.69%
+2.84%
+12.48%
+9.66%
+6.22%
AVTX
Avalo Therapeutics
$14.19
AVTX Price Performance
$16.95 (-16.28%)
$15.5 (-8.45%)
$10.14 (+39.94%)
$8.1 (+75.19%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
AVTX Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AVTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
AVTX has Fair risk level
Risks Indicators

Low volume

High volatilty

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Feb 02, 2026
Initiate
Buy
Guggenheim
Oct 29, 2025
Reiterate
Buy
Piper Sandler
SNY
Sanofi
47.83
+0.72%
MRK
Merck Company
121.93
+1.82%
MLTX
MoonLake Immunotherapeuti
15.51
+5.01%
LLY
Eli Lilly and
1058.18
+3.66%
INSM
Insmed
149.86
-0.77%
What is AVTX current stock price?
What are AVTX stock strengths?
What is AVTX Risk Level?
What is AVTX market cap and volume?
What is AVTX current Stock IQ?
Should I buy AVTX stock right now?
Is AVTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for AVTX?
What does a 'Strong Sell' rating mean for AVTX?
What factors influence AVTX's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-23.69%
+2.84%
+12.48%
+9.66%
+6.22%
AVTX
Avalo Therapeutics
Current Price
$14.19
Runners Also Watch
SNY
Sanofi
47.83
+0.72%
MRK
Merck Company
121.93
+1.82%
MLTX
MoonLake Immunotherapeuti
15.51
+5.01%
LLY
Eli Lilly and
1058.18
+3.66%
INSM
Insmed
149.86
-0.77%

AVTX Price Performance
$16.95 (-16.28%)
$15.5 (-8.45%)
$10.14 (+39.94%)
$8.1 (+75.19%)
AVTX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
AVTX Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AVTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
AVTX has Fair risk level
Risks Indicators

Low volume

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Feb 02, 2026
Initiate
Buy
Guggenheim
Oct 29, 2025
Reiterate
Buy
Piper Sandler
AVTX Stock IQ
Stock Insights
Not Enough Information
AVTX Latest Analysis
Avalo Therapeutics to Participate in Upcoming Investor Conferences. WAYNE Pa. Feb. 04 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics Inc. (Nasdaq: AVTX) a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases today announced that management will participate in the following investor conferences:
Wed Feb 4, 2026
Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down And Bear Case. ) completed enrollment of the Phase 2 LOTUS trial of AVTX-009 the company’.s lead drug candidate.The global trial includes approximately 250 adults with moderate to to evaluate the efficacy and safety of subcutaneous bi-weekly and monthly dosing regimens compared to placebo.Topline data is .Analyst Agarwal sees stock upside even if the HiSCR75 change is around 18%-19% but the upside is capped as some in
Mon Feb 2, 2026
Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating.
Mon Feb 2, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AVTX Stock trends
AVTX Stock performance
AVTX Stock analysis
AVTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.